This article describes the results of a study from the University of California San Francisco. It highlights one of the topics Dr. Micheal Stubblefield mentioned in his presentation at our conference. It comes from a paper that was published in the British Medical Journal Supportive and Palliative Care, July 2022. First author Steven W. Cheung, MD notes the marked incidence of hearing loss and tinnitus in survivors, owing to chemotherapy drugs that contained platinum as well as those that contained taxanes.

Death due to a second primary cancer occurred nearly twice as often among adolescent and young adult cancer survivors compared with the general population, according to study results published in Journal of the National Cancer Institute.

Over the past several years, researchers have developed AI tools that have the potential to make cancer imaging faster, more accurate, and even more informative. And that’s generated a lot of excitement.

Advances over the past 3 decades in improvements in cancer prevention and screening strategies and more effective diagnostics and therapies in cancer care have led to unprecedented declines in death rates from all cancers, including prostate, gynecologic, and colorectal/anal cancers.

In this issue of the Journal, de Vries and colleagues examine the cause-specific late mortality among a multi-center Dutch cohort of Hodgkin lymphoma survivors.

A St Jude Children’s Research Hospital team investigated potential causes of neurocognitive impairments in survivors of childhood Hodgkin Lymphoma survivors.

Radiation therapy plays a critical role in treating head and neck cancers, but it can also lead to lasting late effects that impact quality of life long after treatment ends. One of the most common of these is Radiation Fibrosis Syndrome (RFS) — a chronic condition caused by radiation-induced damage to soft tissues, nerves, and lymphatic structures.

Survivors of childhood Hodgkin lymphoma are at an increased risk of developing an entirely new cancer later in life, according to new research published in Cancer—the American Cancer Society’s international peer-reviewed scientific journal—and conducted at University of Alabama at Birmingham.